Atla-Alternatives to Laboratory Animals

Papers
(The TQCC of Atla-Alternatives to Laboratory Animals is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Extension of the Virtual Cell Based Assay from a 2-D to a 3-D Cell Culture Model64
Spotlight on Three Rs Progress34
Spotlight on Three Rs Progress31
The Safety Assessment of Cosmetic Perfumes by Using In Chemico and In Vitro Methods in Combination with GC-MS/MS Analysis27
The Use of Human Tissues for Research: What Investigators Need to Know27
Conference Diary24
Toxicological Profiling of Potential Shikimate Kinase Inhibitors Against Mycobacterium tuberculosis23
The Development of an Animal Product-free, Precision-cut Lung Slice Cryopreservation and Post-thaw Culture Method21
Progress and Remaining Opportunities to Increase the Use of Animal-free Antibodies in the USA15
In Silico Prediction of Human Clinical Pharmacokinetics with ANDROMEDA by Prosilico: Predictions for an Established Benchmarking Data Set, a Modern Small Drug Data Set, and a Comparison with La13
A History of the Development of Alternatives to Animals in Research and Testing11
The Rise of Three Rs Centres and Platforms in Europe*11
Brazilian National Network of Alternative Methods (RENAMA) 10th Anniversary: Meeting of the Associated Laboratories, May 202210
Conference Diary10
Editorial9
Development of Sensitive In Vitro Protocols for the Biocompatibility Testing of Medical Devices and Pharmaceuticals Intended for Contact with the Eyes: Acute Irritation and Phototoxicity Assess9
Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders9
Spotlight on Three Rs Progress8
Resources Round-up8
Editorial7
Fenugreek Seed Extract Regulates Human Umbilical Vein Endothelial Cell Angiogenesis and Proliferation via the PI3K/Akt/Cyclin D1 Pathway7
2021 Michael Balls Award7
Editorial7
The 19th FRAME Annual Lecture, November 2022: Safer Chemicals and Sustainable Innovation Will Be Achieved by Regulatory Use of Modern Safety Science, Not by More Animal Testing7
Reviewing Current Guidance for the ‘R’ of Replacement and Rethinking it with the ‘Replacement Checklist’6
Editorial6
Addressing Animal Welfare Issues in Fetal Blood Collection for Fetal Bovine Serum Production6
A Cytotoxicity Assay as an Alternative to the Murine Model for the Potency Testing of Bothrops jararaca Venom and Antivenom: An Intralaboratory Pre-validation Study6
Editorial5
Thanks to Reviewers5
The Numbers of Animals Used in Mexico for Scientific and Educational Purposes5
Development of Two Korean IACUC Guidance Documents to Foster Implementation of the Three Rs5
Corrigendum to Case Studies Exemplifying the Transition to Animal Component-Free Cell Culture4
Editorial4
Editorial4
JRC Summer School 20214
Resources Round-up4
Optimisation of a Method for the Differentiation of Human Umbilical Cord-derived Mesenchymal Stem Cells Toward Renal Epithelial-like Cells4
Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Second International Conference on 3Rs Research and Progress, Hyderabad, 20213
The Current Status and Work of Three Rs Centres and Platforms in Europe*3
Accelerating Animal Replacement: How Universities Can Lead — Results of a One-Day Expert Workshop in Zurich, Switzerland3
Editorial3
Introducing the COST Action ‘Improving the Quality of Biomedical Science with 3Rs Concepts’ (IMPROVE)3
The Use of 3-D Models of Echocardiographic Imaging Planes for Teaching Echocardiography Techniques for Use in Dogs and Cats3
Editorial3
Lessons for the Future of NAMs from History, Philosophy and Social Studies of Science3
Case Studies Exemplifying the Transition to Animal Component-free Cell Culture3
Spotlight on Three Rs Progress3
Conference Diary3
The Development and Evaluation of Brain and Heart Cell Lines from a Marine Fish for Use in Xenobiotic-Induced Cytotoxicity Testing3
A New ATLA Associate Editor3
Editorial3
The Application of New Approach Methodologies in Respiratory Disease Research: Their Role in Improving Translational Medicine from Bench to Bedside2
Resources Round-up2
Journeying Through Journals: The Publishing Process and How to Maximise Research Impact2
Conference Diary2
Use of the Allium cepa Model to Assess the Cytogenotoxicity of Luffariella herdmani Marine Sponge Extract2
Modelling the Sorafenib-resistant Liver Cancer Microenvironment by Using 3-D Spheroids2
Transparency in Non-Technical Project Summaries to Promote the Three Rs in Respiratory Disease Research2
The Evolution of Regulatory Toxicology: Where is the Gardener?2
Editorial2
Spotlight on Three Rs Progress2
An Evaluation of the Replacement of Animal-derived Biomaterials in Human Primary Cell Culture2
The Use of Artificial Intelligence for the Fast and Effective Identification of Three Rs-based Literature2
ATLA Best Poster Award2
0.092800140380859